Diffuse infiltrative lymphocytosis syndrome

From WikiMD's Medical Encyclopedia

Revision as of 04:20, 4 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Diffuse infiltrative lymphocytosis syndrome
Synonyms DILS
Pronounce N/A
Specialty N/A
Symptoms Lymphadenopathy, Parotitis, Xerostomia, Peripheral neuropathy
Complications Non-Hodgkin lymphoma, Peripheral neuropathy
Onset Typically in HIV-positive individuals
Duration Chronic
Types N/A
Causes Associated with HIV infection
Risks HIV infection, particularly in individuals of African descent
Diagnosis Clinical evaluation, CD8+ T-cell infiltration in tissues
Differential diagnosis Sjögren's syndrome, Sarcoidosis, Non-Hodgkin lymphoma
Prevention N/A
Treatment Antiretroviral therapy, Corticosteroids
Medication N/A
Prognosis Variable, depends on HIV management
Frequency Rare, more common in HIV-positive individuals of African descent
Deaths N/A


Diffuse Infiltrative Lymphocytosis Syndrome (DILS) is a rare immunological condition characterized by the persistent infiltration of lymphocytes into various tissues, most notably the salivary glands and lungs. This syndrome is often associated with HIV infection and is considered one of the HIV-associated diseases. DILS shares some clinical features with Sjögren's syndrome, a more common autoimmune disorder affecting similar organs, but DILS is distinct in its etiology and association with HIV.

Etiology[edit]

DILS is primarily associated with HIV infection. The exact mechanism by which HIV leads to DILS is not fully understood, but it is thought to involve an abnormal immune response to the virus. In patients with DILS, there is a marked CD8+ lymphocytic infiltration into affected tissues, which differs from the primarily CD4+ lymphocytic infiltration seen in other HIV-related diseases.

Clinical Presentation[edit]

Patients with DILS typically present with symptoms related to the organs involved:

  • Salivary Glands: Enlargement of the parotid glands, dry mouth, and difficulty swallowing.
  • Lungs: Respiratory symptoms such as cough, dyspnea, and occasionally abnormal chest radiographs showing interstitial infiltrates.
  • Other Organs: Less commonly, DILS can affect the kidneys, liver, and eyes.

Diagnosis[edit]

Diagnosis of DILS involves a combination of clinical evaluation, imaging studies, and laboratory tests:

  • HIV Testing: Confirmation of HIV infection is crucial, as DILS is primarily associated with this virus.
  • Imaging: Ultrasound or MRI of the salivary glands and chest X-rays or CT scans for lung involvement.
  • Biopsy: Histological examination of affected tissues showing lymphocytic infiltration.

Treatment[edit]

Treatment of DILS focuses on managing symptoms and controlling the underlying HIV infection:

  • Antiretroviral Therapy (ART): Effective control of HIV with ART can lead to improvement of DILS symptoms.
  • Corticosteroids: These may be used to reduce inflammation in severely affected tissues.
  • Symptomatic Treatment: For example, pilocarpine for dry mouth or supplemental oxygen for respiratory distress.

Prognosis[edit]

The prognosis for patients with DILS varies. With effective HIV management, many patients experience stabilization of symptoms and some may see partial regression of glandular swelling and respiratory issues. However, the chronic nature of the disease can lead to complications over time.

Epidemiology[edit]

DILS is a rare condition, and its prevalence is not well-documented. It appears more frequently in individuals with poorly controlled HIV infection and is less common in the era of effective antiretroviral therapy.

See Also[edit]

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.